PreprintArticleVersion 1Preserved in Portico This version is not peer-reviewed
Selection of an Animal Model for the Production of Leukocyte-Fibrin Rich Platelet Membranes (L-PRF); Standardized Protocol Proposed for Clinical Use and the Use of L-PRF Wound Box®
Version 1
: Received: 3 May 2017 / Approved: 4 May 2017 / Online: 4 May 2017 (08:37:59 CEST)
How to cite:
Crisci, A.; Lombardi, D.; Serra, E.; Lombardi, G.; Cardillo, F.; Crisci, M. Selection of an Animal Model for the Production of Leukocyte-Fibrin Rich Platelet Membranes (L-PRF); Standardized Protocol Proposed for Clinical Use and the Use of L-PRF Wound Box®. Preprints2017, 2017050037. https://doi.org/10.20944/preprints201705.0037.v1
Crisci, A.; Lombardi, D.; Serra, E.; Lombardi, G.; Cardillo, F.; Crisci, M. Selection of an Animal Model for the Production of Leukocyte-Fibrin Rich Platelet Membranes (L-PRF); Standardized Protocol Proposed for Clinical Use and the Use of L-PRF Wound Box®. Preprints 2017, 2017050037. https://doi.org/10.20944/preprints201705.0037.v1
Crisci, A.; Lombardi, D.; Serra, E.; Lombardi, G.; Cardillo, F.; Crisci, M. Selection of an Animal Model for the Production of Leukocyte-Fibrin Rich Platelet Membranes (L-PRF); Standardized Protocol Proposed for Clinical Use and the Use of L-PRF Wound Box®. Preprints2017, 2017050037. https://doi.org/10.20944/preprints201705.0037.v1
APA Style
Crisci, A., Lombardi, D., Serra, E., Lombardi, G., Cardillo, F., & Crisci, M. (2017). Selection of an Animal Model for the Production of Leukocyte-Fibrin Rich Platelet Membranes (L-PRF); Standardized Protocol Proposed for Clinical Use and the Use of L-PRF Wound Box<sup>®</sup>. Preprints. https://doi.org/10.20944/preprints201705.0037.v1
Chicago/Turabian Style
Crisci, A., Federica Cardillo and Michela Crisci. 2017 "Selection of an Animal Model for the Production of Leukocyte-Fibrin Rich Platelet Membranes (L-PRF); Standardized Protocol Proposed for Clinical Use and the Use of L-PRF Wound Box<sup>®</sup>" Preprints. https://doi.org/10.20944/preprints201705.0037.v1
Abstract
Fibrin rich of platelets (PRF®) of Choukroun represents a new step in the therapeutic concept of platelet gel with a simplified processing and biochemical changes little artificial. A valid method of preparation of the PRF must effectively separate the plates by erythrocytes and concentrate without damaging or lysing the plates themselves. In this study the experimental design is to standardize the production of L-PRF in horse directing it to human production. Our hypothesis is that the L-PRF is easy to produce in the horse, without modifications of the human protocol, thus allowing a better standardization of the human protocol. A new device for the preparation and the standardization of L-PRF clots and membranes is the L-PRF Wound Box®. The optical microscopy, most cell bodies were highlighted concentrated in the proximal portion of each membrane, the last 1/4 was observed at the center; the distal part had only residual traces of cell bodies. The L-PRF will form constantly when the phases described above are strictly adhered to. The success of the art L-PRF depends entirely on the speed of blood collection and transfer in centrifuge within a minute and by a temperature of centrifugation and compression is higher than 21°C (between 21 and 30°C). Our experiments on the horse will no doubt be able to improve our understanding on wound healing, in particularly in chronic skin lesions therapy.
Keywords
autologous; buffy coat; growth factor level; platelet-rich fibrin; thrombocyte concentrate
Subject
Medicine and Pharmacology, Hematology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
,
,
,
,
